However, it was readily possible to “construct” a 22.5% subgroup of patients (F2 diagnoses) and a 19.6% subgroup of patients (F3 diagnoses) for which highly significant correlations showed up between IgM levels on one hand, and the global schizophrenia and depression scores on the other. Here, CD40LG is linked to depressive symptom measurement.